Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/33469
Title: | Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study. | |
Authors: | ||
Keywords: | ||
Mesh: | ||
Issue Date: | Apr-2017 | |
Citation: | Am J Cardiovasc Drugs.2017 Apr;(17)2:135-142 | |
Abstract: | Despite the recognized clinical benefit of statins on cardiovascular prevention, providing correct management of hypercholesterolaemia, possible adverse effects of their use cannot be disregarded. Previously published data shows that there is a risk of developing diabetes mellitus or experiencing changes in glucose metabolism in statin-treated patients. The possible determining factors are the drug characteristics (potency, dose), patient characteristics (kidney function, age, cardiovascular risk and polypharmacy because of multiple disorders) and the pre-diabetic state. | |
PMID: | 27837448 | |
URI: | https://hdl.handle.net/20.500.12530/33469 | |
Rights: | openAccess | |
Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos | |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PMC5340834.pdf | 630.06 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.